Drug recall · June 19, 2013
Cefazolin recall
Why: Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use vial, Manufactured in Austria by Sandoz GmbH for Sandoz, Inc. Princeton, NJ 08540, NDC 00781-3451-70 (vial), NDC 00781-3451-96 (box)
- Lots / codes
Lot #: DB2208, Exp 01/16
- Quantity
- 297,200 vials
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- May 30, 2013 · Voluntary: Firm initiated
- Classified
- June 11, 2013
- Reported
- June 19, 2013
- Ended
- July 7, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefazolin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.